HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Ali Khamesipour Selected Research

Cutaneous Leishmaniasis

1/2014Co-existence of cutaneous leishmaniasis with pleural effusion: a case report from Iran.
1/2014A prospective cohort study of cutaneous leishmaniasis risk and opium addiction in south eastern Iran.
8/2013Overexpression of ubiquitin and amino acid permease genes in association with antimony resistance in Leishmania tropica field isolates.
1/2013Dressings combined with injection of meglumine antimoniate in the treatment of cutaneous leishmaniasis: a randomized controlled clinical trial.
1/2013CCR7+ central and CCR7- effector memory CD4+ T cells in human cutaneous leishmaniasis.
11/2012The role of liposome-protamine-DNA nanoparticles containing CpG oligodeoxynucleotides in the course of infection induced by Leishmania major in BALB/c mice.
10/2012Colloidal, in vitro and in vivo anti-leishmanial properties of transfersomes containing paromomycin sulfate in susceptible BALB/c mice.
9/2012Antioxidants and proinflamatory cytokines in the sera of patients with cutaneous leishmaniasis.
1/2012Preparation and evaluation of niosomes containing autoclaved Leishmania major: a preliminary study.
1/2010CD8+ T cells as a source of IFN-γ production in human cutaneous leishmaniasis.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Ali Khamesipour Research Topics

Disease

31Leishmaniasis
12/2015 - 12/2002
15Cutaneous Leishmaniasis
01/2014 - 01/2005
10Infection
01/2015 - 08/2007
2Malaria
01/2015 - 12/2014
2Communicable Diseases (Infectious Diseases)
11/2014 - 12/2013
2Dehydration (Water Stress)
04/2009 - 08/2007
1Echinococcosis (Hydatid Cysts)
07/2015
1Granuloma
04/2015
1Pemphigus (Pemphigus Vulgaris)
06/2014
1Autoimmune Diseases (Autoimmune Disease)
06/2014
1Tuberculosis (Tuberculoses)
01/2014
1Pleural Effusion (Pleural Effusions)
01/2014
1Photophobia (Light Sensitivity)
11/2013
1Pain (Aches)
11/2013
1Hemangioma (Angioma)
11/2013
1Eye Injuries (Eye Injury)
11/2013
1Leprosy (Hansen's Disease)
12/2009
1Pruritus (Itching)
12/2006
1Visceral Leishmaniasis (Kala Azar)
09/2004
1Laryngeal Neoplasms (Laryngeal Cancer)
11/2003

Drug/Important Bio-Agent (IBA)

11AntigensIBA
12/2015 - 08/2007
10VaccinesIBA
11/2014 - 05/2005
10Liposomes (Liposome)IBA
09/2013 - 08/2007
9meglumine antimoniateIBA
09/2014 - 01/2005
4Biological Markers (Surrogate Marker)IBA
11/2014 - 11/2006
4OligodeoxyribonucleotidesIBA
11/2012 - 04/2008
4CPG-oligonucleotideIBA
10/2011 - 08/2007
3CytokinesIBA
06/2014 - 01/2010
3Carbon MonoxideIBA
01/2014 - 08/2007
3Paromomycin (Paromomycin Sulfate)FDA LinkGeneric
10/2012 - 03/2005
2Leishmaniasis VaccinesIBA
11/2014 - 01/2013
2Interleukin-6 (Interleukin 6)IBA
06/2014 - 09/2012
2Opium (Papaveretum)IBA
01/2014 - 11/2003
2Mustard Gas (Sulfur Mustard)IBA
11/2013 - 11/2013
2aluminum sulfate (alum)IBA
11/2006 - 09/2004
1A-Form DNA (A-DNA)IBA
07/2015
1Hematoxylin (Haematoxylon)IBA
04/2015
1Eosine Yellowish-(YS) (Eosin)IBA
04/2015
1LigandsIBA
01/2015
1Amphotericin B (Amphotericin)FDA LinkGeneric
01/2015
1Nystatin (Mycostatin)FDA LinkGeneric
01/2015
1Blood Group Antigens (Blood Groups)IBA
12/2014
1InterleukinsIBA
06/2014
11,2- dioleoyloxy- 3- (trimethylammonium)propaneIBA
12/2013
1ProlactinIBA
11/2013
1HormonesIBA
11/2013
1ChemokinesIBA
11/2013
1Chemokine CCL5IBA
11/2013
1Interleukin-8 (Interleukin 8)IBA
11/2013
1Immunoglobulin G (IgG)IBA
11/2013
1Immunoglobulins (Immunoglobulin)IBA
11/2013
1Phospholipases (Phospholipase)IBA
09/2013
1AntimonyIBA
08/2013
1Interleukin-2 (IL2)IBA
01/2013
1Membrane Glycoproteins (Membrane Glycoprotein)IBA
12/2012
1DNA (Deoxyribonucleic Acid)IBA
11/2012
1tebufenozide (Mimic)IBA
11/2012
1AntioxidantsIBA
09/2012
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2012
1GuanosineIBA
07/2012
1CytidineIBA
07/2012
1Verapamil (Calan)FDA LinkGeneric
03/2012
1alginic acid (sodium alginate)IBA
10/2011
1polylactic acid-polyglycolic acid copolymer (PLGA)IBA
05/2011
1SilkFDA Link
12/2009
1PhospholipidsIBA
11/2009
1Interleukin-12 (IL 12)IBA
06/2008
1Leishmania major stress-inducible protein 1IBA
04/2008
1Antimony Sodium Gluconate (Sodium, Stibogluconate)IBA
11/2007
1imiquimod (Aldara)FDA LinkGeneric
12/2006
1MeglumineFDA Link
01/2005
1Zinc SulfateFDA Link
01/2005
1autoclaved Leishmania major vaccineIBA
09/2004
1Aluminum Hydroxide (Algeldrate)FDA Link
09/2004

Therapy/Procedure

2Drug Therapy (Chemotherapy)
01/2015 - 11/2014
2Immunotherapy
11/2014 - 06/2012
2Fluid Therapy (Oral Rehydration Therapy)
04/2009 - 08/2007
1Aftercare (After-Treatment)
06/2014
1Microspheres (Microsphere)
10/2011
1Nanospheres
05/2011
1Intralesional Injections
01/2005
1Injections
12/2002